Cancer Investigation
Overview
Cancer Investigation is a peer-reviewed journal that focuses on the latest advancements in cancer research and clinical investigations. It covers a wide range of topics, including cancer biology, genetics, epidemiology, diagnosis, treatment, and prevention. With its rigorous scientific approach, the journal provides valuable insights into the understanding and management of various types of cancer, making it an essential resource for researchers, clinicians, and healthcare professionals in the field.
Details
Details
Abbr.
Cancer Invest
Start
1983
End
Continuing
Frequency
Eight no. a year, 2005-
p-ISSN
0735-7907
e-ISSN
1532-4192
Country
United Kingdom
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 3490
93
SJR / Ranks: 7464
604
CiteScore / Ranks: 7822
3.40
JIF / Ranks: 4480
2.4
Recent Articles
1.
2.
Faulkner L, Howells L, Lehman S, Cowley C, Sidat Z, Shaw J, et al.
Cancer Invest
. 2025 Feb;
43(2):119-140.
PMID: 39989311
Genomic sequencing of tumours improves patient outcomes through implementation of precision oncology. At present, genomic testing is mainly confined to research settings, with samples sent to biopharmaceutical companies for analysis....
3.
Olivieri D, Gopal A, Uldrick T, Menon M
Cancer Invest
. 2025 Feb;
43(2):141-148.
PMID: 39921375
Background: Human immunodeficiency virus is associated with the development of various aggressive non-Hodgkin B-cell lymphomas (NHL). Despite this, people living with HIV (PLWH) are often excluded from clinical trials. Here...
4.
5.
de Souza C, Dos Santos M
Cancer Invest
. 2025 Jan;
43(2):149-160.
PMID: 39868729
Although breast, cervical, endometrial, and ovarian cancers account for more than 43% of new cases in 2023 in Brazilian women, no national studies were found on the incidence, risk factors,...
6.
Bukhari S, Altaf S, Saleem H, Fadoo Z, Belgaumi A, Moatter T, et al.
Cancer Invest
. 2025 Jan;
43(2):161-171.
PMID: 39851090
Accurate and timely diagnosis of t(9;22)-positive leukemias is vital to improving survival in pediatric patients. In low-resource settings, where healthcare disparities are exacerbated by limited resources, cost-effective and efficient diagnostic...
7.
Salm H, Eichler M, Bahr J, Andreou D, Schmidt C, Uhlig S, et al.
Cancer Invest
. 2025 Jan;
43(1):24-32.
PMID: 39797618
Objective: The ExPRO (External factors influencing patient reported outcomes of patients with malignant diseases) study explored associations between QoL data and environmental factors on the day of questionnaire completion: mean...
8.
Mosadegh M, Noori Goodarzi N, Erfani Y
Cancer Invest
. 2025 Jan;
43(1):33-58.
PMID: 39760426
Apoptosis, or programmed cell death, is a fundamental biological process essential for maintaining tissue homeostasis. Dysregulation of apoptosis is implicated in a variety of diseases, including cancer, neurodegenerative disorders, and...
9.
Hinz A, Friedrich M, Schulte T, Petrowski K, Tibubos A, Hartung T
Cancer Invest
. 2025 Jan;
43(1):103-113.
PMID: 39749569
Objective: Cancer patients frequently report sleep problems. The Pittsburgh Sleep Quality Index (PSQI) is a 19-item instrument for assessing sleep problems. The main objective of this study was to analyze...
10.
Kapoor G, Prakash S, Jaiswal V, Singh A
Cancer Invest
. 2024 Dec;
43(1):1-23.
PMID: 39648223
Recent research has underscored the pivotal role of chronic inflammation in cancer development. Investigations have elucidated key molecular mechanisms underpinning inflammation-related cancer. Extrinsic pathway, driven by inflammatory conditions and intrinsic...